Skip to content
Clinical Research Pathways
  • Home
  • Privacy Policy
Subsctibe
Clinical Research Pathways

[In the News] Executive Director Marjorie A. Speers, Ph.D., Speaks Out on Need for Diversity in COVID-19 Vaccine Trials

Home / [In the News] Executive Director Marjorie A. Speers, Ph.D., Speaks Out on Need for Diversity in COVID-19 Vaccine Trials

Clinical Research Pathways Executive Director Marjorie A. Speers, Ph.D., an epidemiologist and longstanding advocate for diversity in clinical research, has been featured in a number of news stories on the need to include Black and Latino participants in COVID-19 vaccine trials. To do otherwise, will “end up creating a greater health disparity,” she says.

Why Diversity Matters In COVID-19 Vaccine Trials

Verywell Health, Published August 29, 2020

Read the full article >>

Coronavirus Vaccine Trials Have Been Slow to Recruit Latino People

Latin Post, Published August 16, 2020

Read the full article >>

Here’s What We Know About the Demographic Makeup of the COVID-19 Vaccine Trials

Healthline, Published August 9, 2020

Read the full article >>

Black Volunteers, Black Fears and the COVID-19 Vaccine Trials

The Final Call, Published August 4, 2020

Read the full article >>

The Pressure is on for COVID-19 Vaccine Trials to Reflect U.S. Diversity

Los Angeles Time, Published July 24, 2020

Read the full article >>

Search

Recent Posts

  • D-Bal Review – Is It Really The Safest Dianabol Alternative?
  • HGH-x2 Review: Is it the best HGH Booster that genuinely provides you mind-blowing results?
  • TestRX Review [2022]: 8 Weeks Testimonial – Read Before You Buy!
  • Leanbean Review 2022 – Does This Product Really Work As It Claims
  • Testofuel Review: Does it help you maintain the testosterone level?

Weekly Gatherings

  • All Posts
  • Health Supplements News

Useful Links

  • Diversity
  • Contacts
  • Privacy Policy
  • Our Beliefs

For latest Updates, Join our newsl.

© 2022 Clinical Research Pathways

  • Home
  • Privacy Policy